Risvan (risperidone ISM) receives FDA approval as a treatment for schizophrenia – Laboratorios Farmacéuticos Rovi, S.A
Laboratorios Farmacéuticos Rovi, S.A. has announced that the FDA has authorised the marketing of Risvan (risperidone ISM ) for the treatment of schizophrenia in adults. Risperidone ISM is… read more.
